Confluence Wealth Services, Inc.

Position in CHRS — Coherus Oncology, Inc.

CIK 1910411 MCMURRAY, PA

Position in CHRS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$27,724

+$27,533 QoQ

Shares Held

19,803

+164925.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 24 holders

Holding Since

Dec 2021

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Confluence Wealth Services, Inc. holds $2,485,829 across 5 Biotechnology names. CHRS ranks #4 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	3,792	$1,409,372
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,642	$815,630
3	DFTX	Definium Therapeutics, Inc.	4,796	$225,603
4	CHRS	Coherus Oncology, Inc. This page	19,803	$27,724
5	VTGN	Vistagen Therapeutics, Inc.	32,610	$7,500

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,724	19,803	+164925.0%	Shares	Sole	2026-07-22
2021-12-31	$191	12	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.